Popular Keywords
Amnesia
Analgesics
Anesthesia
Anesthesiology
Cardiothoracic Anesthesia
Cerebrovascualr Anesthesia
Correspondence to Author: Haynice Eeiva,
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, USP,HCFMRP-USP, Brazil
Abstract:
Research indicates that the combination of dextroketamine and dexmedetomidine enables children to be safely and effectively sedated throughout various anaesthetic operations. In this association, known as Ketodex in the literature, ketamine not only counteracts the sympatholytic effects of dexmedetomidine but also lessens the negative effects of ketamine in the central nervous system, including sialorrhea, with the added benefit of not causing respiratory depression or bronchial hyperreactivity. We describe a difficult case with a youngster who had many punctures that rendered vascular access impractical, leading to thrombosis of the venous bed. The injectable Ketodex option proved to be a safe, painless, and effective sedation alternative in this circumstance
Keywords: Children; Intramuscularly; Ketodex; Procedural sedation
INTRODUCTION
Both surgical and noninvasive treatments are still often used
and essential in the care of kids with both acute and chronic
illnesses. Procedure-related problems are more likely to occur
in individuals with underlying co-morbid illnesses, even if procedural sedation is usually safe and effective.In order to lessen
the incidence of sevoflurane agitation and with the benefit of not producing respiratory depression, ketamine, an NMDA receptor antagonist, has been utilised extensively as an alternative to the use of inhalational drugs for sedation, analgesia, and
amnesia.At clinical dosages, the highly selective alpha-2 agonist
dexmedetomidine also exerts sedative, analgesic, and anxiolytic effects without causing appreciable respiratory depression.
Ketamine and dexmedetomide have been shown to be safe and
efficient in achieving successful sedation, even when used by
non-anesthesiologists.
The intramuscular route is recommended for patients who are
uncooperative or unable to take oral medications because it
offers a rapid systemic action, with nearly 80% biodisponibility
and a plasma concentration peak in approximately 15 minutes.
Subsequently, the intramuscular delivery of both Ketamin and
Dexmedetomidine may present a compelling alternative for
procedural sedation in kids, who are typically uncooperative,
agitated, or have trouble gaining venous access.In order to provide parenteral antibiotic therapy for a thirteen-year-old child
with acute ventriculitis, we report the use of an intramuscular
combination of ketamine and dexmedetomide for procedural
sedation.
Case Report
A 13-year-old child with post-natal neuropathy, weighing 36 kg,
was admitted to the Emergency Unit with a fever (39oC) and
headache after eight hours of fasting. After a lumbar puncture
and cranial tomography, the child’s condition was determined
to be ventriculitis. Antibiotic therapy had to start right away. He
arrived nervously in the radio intervention room without a tracheostomy, gastrostomy, or venous access, and he had a history of multiple peripheral and deep vein thromboses (thrombosis of the jugular, subclavian, and femoral veins). To perform
suprahepatic central venous access under the guidance of radiography and ultrasound, anaesthesia was required. Therefore,
a combination of dextroketamine and dexmedetomidine was
decided to be injected intramuscularly. A 30G 13x4.5 mm needle was used to administer 3 ml of 1% lidocaine as a previous
local anaesthetic to the vastus medialis muscle and a dilution
was made in a 5-milliliter syringe with a concentration of 20 mg/
ml dextrose and 10 mcg/ml dexmedetomidine. We decide to
use a 22G needle and a dose of 1 mcg/kg of dexmedetomide in
combination with 2 mg/kg of dextroketamine (3.6 ml solution).
The child achieved state 2 on the Paediatric Sedation State Scale
(PSSS) [5] in less than five minutes (Figure 1). The radiology technician injected lidocaine into the child, but the child did not react and stayed motionless for the entire 35-minute procedure.
Peripheral oxygen saturation was 98%, eupneic, hemodynamically stable, heart rate was 80–90 beats per minute, and non-invasive arterial pressure was between 100–110 mmHg. It was
not required to use extra oxygen (Figures 1 and 2). The young
person was recommended to the post-anesthetic room, where
they were released after 20 minutes of spontaneous breathing
Discussion
The Food and Drug Administration (FDA) in the United States
first approved dexmedetomidine, an alpha-2-adrenergic agonist, in 1999 for the sedation of adults undergoing mechanical
ventilation. In 2009, the FDA again approved the medication for
adult Monitored Anaesthesia Care (MAC). It has been successfully used in a number of clinical scenarios, including sedation
during mechanical ventilation, procedural sedation, postoperative analgesia, prevention of emergence delirium, post-anesthesia shivering control, and the treatment of withdrawal from
various substances, including opioids and benzodiazepines, despite not having a specific FDA-approved indication for use in
infants and children.
Concerns regarding the anaesthetic management of our patients included the requirement for an effective sedation to carry out a potentially painful procedure without compromising hemodynamic or ventilatory function. In addition to the analgesia that dexmedetomidine does not provide, ketamine therapy increases heart rate (HR) and blood pressure (BP) to counteract dexmedetomidine’s bradycardia and has a quicker onset than dexmedetomidine alone. Many of the potentially harmful effects of ketamine are avoided by dexmedetomidine, such as emergence agitation, excessive salivation, and stimulation of the cardiovascular system (increased heart rate and blood pressure) [6]. As the combination of dexmedetomidine and ketamine continues to show promise in prospective trials, case series, and isolated case reports, clinical experience with this combination is growing. But even though dexmedetomidine works well when used alone to sedate patients during non-painful radiologic imaging, it might not work as well when used alone to sedate patients during painful procedures.
A single intramuscular dosage of dexmedetomidine and ketamine was sufficient to induce a good level of sedation in our patient. A retrospective review of this combination for cardiac catheterization sedation in paediatric patients with heart disease was conducted by Mester et al. After three minutes of an intravenous bolus injection of ketamine (2 mg/kg) and dexmedetomidine (1 mg/kg), dexmedetomidine was continuously infused. The insertion of the venous and arterial cannulas and their infiltration into the groyne caused no patient to react. After repositioning their airways, two patients who had upper airway obstructions recovered. The highest PaCo2 reading was 48 mmHg, and there was no evidence of central apnea. Dexmedetomide and ketamine were successfully used by McVey and Tobias to provide procedural sedation for lumbar punctures used to create spinal anaesthesia in 12 paediatric patients.The ketamine and dexmedetomidine dosage schedule matched the information provided by Mester et al. Additional research has demonstrated that even at low doses, the combination of ketamine and dexmedetomidine provides children with safe and efficient sedation during a variety of surgical procedures.
For procedures requiring a deep level of sedation while preserving spontaneous breathing, Joseph Tobias has repeatedly shown the value of using dexmedetomidine in addition to ketamine [16]. Patients with severe co-morbid conditions, such as congenital heart disease, sleep apnea, pulmonary hypertension, tracheal compression from a mediastinal mass, and impaired cardiac and respiratory function, have been included in a number of reports. These studies show that a combination of dexmedetomidine and ketamine efficiently produces the required degree of sedation with the lowest possible risk of side effects. Tobias also came to the conclusion that the best course of action for procedural sedation appears to be the intravenous bolus injection of both ketamine (1-2 mg/kg) and dexmedetomidine (1 μg/kg) to start the sedation process. In this case, the two agents can be given from a single syringe in tandem [16]. Ketamine’s distinct qualities and adaptability have made it more and more well-liked in prehospital and emergency medicine worldwide. It has been reported that intramuscular, oral,or intranasal ketamine administration has been effective when intravenous access is challenging. Additionally, dexmedetomidine can be administered intravenously or intramuscularly. For premedication, a dose of 0, 33-0, 67 mcg/kg IV or 2, 5 mcg/kg IM should be administered via injection 15 minutes prior to the procedure. Therefore, it would be normal for the intramuscular combination of both medications to be used. To the best of our knowledge, there are no published reports on the intramuscular administration of dexmedetomidine and dextroketamine in humans. A study that links the two medications intramuscularly in swine has been published, demonstrating the combination’s safety and effective sedation. In this case study, it was found that administering the drugs intramuscularly in a bolus at the recommended doses and combining them in one syringe proved to be a very painless, safe, and effective way to accomplish a procedure without agitation. It also ensured hypnosis and analgesia, prevented hypoventilation or any alteration in respiratory pattern, and served as a great substitute for sedation in children with co-morbidities. In the practise of anaesthesia, ketodex is a very versatile mixture. Finding a position in a growing number of medical operations. We proved that administering the combination intramuscularly with a single syringe is a workable substitute for sedation during paediatric surgery.
Conclusion
A thirteen-year-old boy with acute ventriculitis was effectively
sedated for transhepatic central venous access with a single
intramuscular dosage of dexketamine and dexmedetomidine.
Because there is no venous access and spontaneous ventilation
must be maintained without agitation from sevoflurane or pollution from the environment, this combination of agents was
selected.The use of any anaesthetic agent during a procedure
carries the risk of both hemodynamic and respiratory depression. In light of these worries, procedural sedation requires adequate monitoring, access to resuscitation drugs, and airway
equipment. Keeping these warnings in mind, we think that, as
demonstrated in the case study, the combination of dextroketamine and dexmedetomidine (Ketodex) administered intramuscularly could be a viable option for procedural sedation in
paediatric patients, even those with co-morbid conditions. in
different medical situations.Valid information regarding safety, time of awakening, and cost effectiveness may be obtained
from future clinical trials comparing various sedation regimens
with other sedatives and routes of administration.
References
1. Malviya S, Voepel-Lewis T, Eldevik OP, Rockwell DT, Wong
JH, et al. (2000) Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth 84: 743-748.
2. Abu-Shahwan I, Chowdary K (2007) Ketamine is effective
in decreasing the incidence of emergence agitation in children undergoing dental repair under sevoflurane general
anesthesia. Paediatr Anaesth 17: 846-850.
3. Kamibayashi T, Maze M (2000) Clinical uses of alpha2-adrenergic ago-nists. Anesthesiology 93: 1345-1349.
4. Corcuera-Flores JR, Silvestre-Rangil J, Cutando-Soriano A,
López-Jiménez J (2016) Current methods of sedation in
dental patients - a system-atic review of the literature.
Med Oral Patol Oral Cir Bucal 21: 579-586.
5. Cravero JP, Askins N, Sriswasdi P, Tsze DS, Zurakowski
D, et al. (2017) Validation of the Pediatric Sedation State
Scale. Pediatric 139: 20162897.
6. Tobias JD (2007) Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit
Care Med 8: 115-131.
7. Levanen J, Makela ML, Scheinin H (1995) Dexmedetomidine premedica-tion attenuates ketamine-induced cardiostimulatory effects and postanes-thetic delirium. Anesthesiology 82: 1117-1125.
8. Mester R, Easley RB, Brady KM, Chilson K, Tobias JD (2008)
Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization. Am J Ther 15: 24-30.
9. McVey JD, Tobias JD (2010) Dexmedetomidine and ketamine for sedation during spinal anesthesia in children. J
Clin Anesth 22: 538-545.
10. Bozdogan N, Sener M, Caliskan E, Kocum A, Aribogan A
(2008) A combi-nation of ketamine and dexmedetomidine sedation with caudal anesthesia during incarcerated inguinal hernia repair in three high-risk infants. Pediatr
Anesth 18: 1009-1011.
11. Barton KP, Munoz R, Morell VO, Chrysostomou C (2008)
Dexmedeto-midine as the primary sedative during invasive procedures in infants and toddlers with congenital
heart disease. Pediatr Criti Care Med 9: 612-615.
12. Luscri N, Tobias JD (2006) Monitored anesthesia care with
a combination of ketamine and dexmedetomidine during
magnetic resonance imaging in three children with trisomy 21 and obstructive sleep apnea. Peadiatr An-aesth 16:
782-786.
13. Mason KP, Zurakowski D, Zgleszewski SE, Robson CD, Carrier M, et al.(2008) High dose dexmedetomidine as the
sole sedative for pediatric MRI. Paediatr Anaesth18 :403-
411.
14. Tobias JD, Berkenbosch JW (2002) Initial experience with
dexmedetomi-dine in paediatric-aged patients.Paediatr
Anaesth 12: 171-175.
15. Jalowiecki P, Rudner R, Gonciarz M, Kawecki P, Petelenz M,
et al. (2005) Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy.
Anesthesiology 103: 269-273.
16. Goyal R, Singh S, Shukla RN, Patra AK, Bhargava DV (2013)
Ketodex a combination of dexmedetomidine and ketamine for upper gastrointestinal endoscopy in children: a
preliminar report. J Anesth 27: 461-463.
17. Tobias JD (2012) Dexmedetomidine and ketamine: an effective alternative for procedural sedation. Pediatr Crit
Care Med 13: 423-427.
18. Gales A, Maxwell S (2018) Ketamine: Recent Evidence and
Current Uses. ATOTW 381: 1-7.
19. 19. Naaz S, Ozair E (2014) Dexmedetomidine in Current
Anaesthesia Prac-tice-A review. J Clin Diagn Res 8: 01-04.
20. Santos M, Bertrán de Lis BT, Tendillo FJ (2016) Effects of
intramuscular dexmedetomidine in combination with ketamine or alfaxalone in swine. Vet Anaesth Analg 43: 81-85.
Citation:
Haynice Eeiva. An Unique Method to Paediatric Procedural Anaesthesia: Integrating IM Precedex and Ketam. Journal of Anaesthesia 2024.
Journal Info
- Journal Name:Journal of Anaesthesia
- Impact Factor: 1.9**
- ISSN: 2995-8318
- DOI: 10.52338/joa
- Short Name: JOA
- Acceptance rate: 55%
- Volume: (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility